What Analyst Projections for Key Metrics Reveal About Integer (ITGR) Q1 Earnings

Core Insights - Integer (ITGR) is expected to report quarterly earnings of $1.27 per share, reflecting an 11.4$431.84 million, a 4.1% increase from the previous year [1] - Over the last 30 days, the consensus EPS estimate has been revised upward by 1.6%, indicating a positive reassessment by analysts [1][2] Revenue Estimates - Analysts predict 'Sales- Medical Sales- Cardiac Rhythm Management & Neuromodulation' to reach $162.26 million, showing a year-over-year increase of 3.8$22.58 million, reflecting a significant decline of 22.5% from the prior-year quarter [4] - 'Sales- Medical Sales- Cardio & Vascular' is expected to be $247.02 million, indicating an 11.4% increase compared to the same quarter last year [5] Market Performance - Integer shares have decreased by 1.5% over the past month, contrasting with the Zacks S&P 500 composite's decline of 8.9% [6] - The company holds a Zacks Rank of 3 (Hold), suggesting it is likely to perform in line with the overall market in the near term [6]